Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

open-label duloxetine trials coming soon

Posted by jrbecker on February 26, 2003, at 13:19:12

see below or call 1-877-CTLILLY (1-877-285-4559)...

Open-Label Treatment with Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients with Major Depression

This study is not yet open for patient recruitment.

Sponsored by
Eli Lilly and Company

The purposes of this study are to determine:

The safety of duloxetine and any side effects that might be associated with it.

Whether duloxetine can help patients with major depression.

The safety associated with switching from a medication you may be taking for depression to taking duloxetine.

It is possible that information collected during this study will be analyzed by the sponsor in the future to evaluate duloxetine for other possible uses or for other medical or scientific purposes other than those currently proposed.

Condition Treatment or Intervention Phase
Major Depressive Disorder Drug: duloxetine Phase III

MEDLINEplus related topics: Mental Health

Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study


Ages Eligible for Study: 18 Years and above , Genders Eligible for Study: Both
Inclusion Criteria:

You must be at least 18 years old.
You must have been diagnosed with major depressive disorder.
You must be able to visit the doctor's office once a week to once every 2 weeks for a total of 14 weeks
Exclusion Criteria:

You are a woman and are pregnant or breastfeeding.
You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder.
You have had a primary diagnosis of an anxiety disorder within the past 6 months.
You have a history of alcohol or drug dependence or abuse within the past 6 months.
Location and Contact Information

Call Center 1-877-CTLILLY (1-877-285-4559)
Los Angeles, California, United States
Carisbad, California, United States
Stanford, California, United States
Cromwell, Connecticut, United States
Coral Springs, Florida, United States
Gainesville, Florida, United States
Miami, Florida, United States
Atlanta, Georgia, United States
Bangor, Maine, United States
Boston, Massachusetts, United States
New York
Rochester, New York, United States
New York, New York, United States
Cincinnati, Ohio, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Dallas, Texas, United States
Houston, Texas, United States
San Antonio, Texas, United States
Falls Church, Virginia, United States
Richmond, Virginia, United States
Charlottesville, Virginia, United States
Seattle, Washington, United States
West Allis, Wisconsin, United States
More Information

Study ID Numbers 6476
Study Start Date December 2002; Estimated Completion Date December 2003
Record last reviewed August 2002
NLM Identifier NCT00042562 processed this record on 2003-02-26




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:jrbecker thread:204032